Navigation Links
Nektar Therapeutics Reports Third Quarter 2009 Financial Results
Date:11/4/2009

- (40,444) Increase (decrease) in deferred revenue (2,722) (11,972) Increase (decrease) in other liabilities (2,823) 2,474 ------ ----- Net cash used in operating activities $(90,453) $(115,065) Cash flows from investing activities: Purchases of investments (298,054) (411,417) Sales of investments 11,923 28,590 Maturities of investments 266,202 506,348 Purchases of property and equipment (10,763) (15,064) Transaction costs from Novartis pulmonary asset sale (4,440) - Investment in Pearl Therapeutics Inc. - (4,236) --- ------ Net cash (used in) provided by investing activities $(35,132) $104,221 Cash flows from financing activities: Payments of loan and capital lease obligations (935) (1,910) Proceeds from issuances of common stock 3,821 477 ----- --- Net cash provided by (used in) financing activities $2,886 $(1,433) ------ ------- Effect of exchange rates on cash and cash equivalents (108) (303) ---- ---- Net decrease in cash and cash equivalents $(122,807) $(12,580) Cash and cash equivalents at beginning of period 155,584 76,293
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2009 on Wednesday, November 4, 2009, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics to Host Conference Call to Discuss Todays Announcement of a New Partnership for NKTR-118 and NKTR-119
3. AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
4. Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City
5. Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
7. Nektar Therapeutics Reports First Quarter 2009 Financial Results
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
9. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
10. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
11. Nektar Announces Retirement of Irwin Lerner from Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... January 22, 2015 Crystal Diagnostics (CDx) Xpress ... it has received AOAC-PTM Certifications for the six non-O157 Shiga ... O145; collectively referred to as STEC or the “Big-6”) as ... forming unit (cfu) per 325 g of raw ground beef ...
(Date:1/22/2015)... Wilmington, DE (PRWEB) January 22, 2015 ... the Pistoia Alliance, which helps companies check the legal ... set to expand to China. , As their ... companies are globally adopting software solutions built as a ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Global Compliance Service for Controlled Substances to Expand to China 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... Group, Inc. (Nasdaq:  ENCO), (the "Company"), a full ... in over 30 countries for many of the ... that, on October 20, 2010, it received notification ... has determined to delist the Company,s securities from ...
... DIEGO, Calif., Oct. 22 EBD Group, the leading ... announced that BIOCOM has selected partneringONE® as the partnering ... to be held February 22–24, 2011 at the Estancia ... is an exclusive global partnering and networking forum for ...
... N.C. -- Being the right size and existing in the ... be the secrets to improving the efficiency of chemical catalysts ... When matter is in this transitional state, a catalyst ... catalyst particle size and temperature, according to a pair of ...
Cached Biology Technology:Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 2Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 3Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 4EBD Group to Power Partnering at BIOCOM's Global Life Science Partnering Conference 2EBD Group to Power Partnering at BIOCOM's Global Life Science Partnering Conference 3Smaller is better in the viscous zone 2
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB SM ... (GCP) audit to confirm its adherence to current U.S. ... HITLAB to conduct regulated smart device and smart phone ... and research quality. "HITLAB is determined to ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
(Date:12/15/2014)... DUBLIN , Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition is a technology ... measures the overall facial feature of a person such ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... certain agronomic practices, farmers can significantly reduce the ... the soil, according to Iowa State University research. ... engineering, and Antonio Mallarino, professor of agronomy, have ... through soil into tiling systems from several different ...
... of insoluble proteins appear in patients, brains. These aggregates ... as amyloid beta in Alzheimer,s disease, but they are ... that are normally present in a soluble form in ... thought to be accidental inclusions in the aggregates, much ...
... release is available in Spanish . , A ... low serum (blood) zinc concentrations during an observational study funded ... of Aging. The scientists found that those with ... to develop pneumonia than those with low concentrations. The ...
Cached Biology News:Switchgrass lessens soil nitrate loss into waterways, ISU researcher says 2Proteins linked with Alzheimer's, other neurodegenerative diseases found to clump in normal aging 2Proteins linked with Alzheimer's, other neurodegenerative diseases found to clump in normal aging 3Adequate zinc eases pneumonia in elderly 2
sodium channel, nonvoltage-gated 1 alpha,...
MOUSE ANTI HUMAN B-CELLS (FMC7):FITC Immunogen: HRIK cells - Human B-Lymphoblastoid line...
RABBIT ANTI PARATHION...
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
Biology Products: